(OE) Prot# BN42489: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomakers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Hungtington's Disease

Project: Research project

Project Details

StatusActive
Effective start/end date3/6/2311/30/26

Funding

  • INC Research, LLC (NOT SPECIFIED)
  • Genentech, Inc. (NOT SPECIFIED)